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Myocardial perfusion reserve compared
with peripheral perfusion reserve:
A [13N]ammonia PET study
A. M. Scholtens, MD,a R. A. Tio, MD, PhD,b,f A. Willemsen, PhD,c
R. A. J. O. Dierckx, MD, PhD,c H. H. Boersma, PharmD, PhD,c,d,f
C. J. Zeebregts, MD, PhD,e,f A. W. J. M. Glaudemans, MD,c
and R. H. J. A. Slart, MD, PhDc,f
Introduction. [13N]ammonia PET allows quantification of myocardial perfusion. The
similarity between peripheral flow and myocardial perfusion is unclear. We compared perfu-
sion flow in the myocardium with the upper limb during rest and adenosine stress
[13N]ammonia PET to establish whether peripheral perfusion reserve (PPR) correlates with
MPR.
Methods. [13N]ammonia myocardial perfusion PET-scans of 58 patients were evaluated
(27 men, 31 women, age 64 ± 13 years) and were divided in four subgroups: patients with
coronary artery disease (CAD, n 5 15), cardiac syndrome X (SX, n 5 14), idiopathic dilating
cardiomyopathy (DCM, n 5 16), and normal controls (NC, n 5 13). Peripheral limb perfusion
was measured in the muscular tissue of the proximal upper limb and quantified through a
2-tissue-compartment model and the PPR was calculated (stress/rest ratio). MPR was also
calculated by a 2-tissue-compartment model. The PPR results were compared with the MPR
findings.
Results. Mean myocardial perfusion increased significantly in all groups as evidenced by
the MPR (CAD 1.99 ± 0.47; SX 1.39 ± 0.31; DCM 1.72 ± 0.69; NC 2.91 ± 0.78). Mean
peripheral perfusion also increased but not significantly and accompanied with great variations
within and between groups (mean PPR: CAD 1.30 ± 0.79; SX 1.36 ± 0.71; DCM 1.60 ± 1.22;
NC 1.27 ± 0.63). The mean difference between PPR and MPR for all subpopulations varied
widely. No significant correlations in flow reserve were found between peripheral and myo-
cardial microcirculatory beds in any of the groups (Total group: r 5 20.07, SEE 5 0.70, CAD:
r 5 0.14, SEE 5 0.48, SX: r 5 0.17, SEE 5 0.30, DCM: r 5 20.11, SEE 5 0.71, NC:
r 5 20.19, SEE 5 0.80).
Conclusion. No correlations between myocardial and peripheral perfusion (reserve) were
found in different patient populations in the same PET session. This suggests a functional
difference between peripheral and myocardial flow in the response to intravenously adminis-
tered adenosine stress. (J Nucl Cardiol 2011;18:238–46.)
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INTRODUCTION
Evaluation of systemic arterial dilatory function,
mostly by ultrasonography, is a widely available tech-
nique. Its findings have been shown to predict coronary
artery disease.1 For the microvascular component of
myocardial and peripheral perfusion, these correlations
are less obvious and probably different.2 Patients with
coronary artery disease (CAD) risk factors such as
hypercholesterolemia and diabetes mellitus exhibit not
only large-vessel dysfunction but also microvascular
dysfunction, e.g., reduced responses to vasoactive sub-
stances such as adenosine and dipyridamole.3 PET is an
accurate technique for the quantification of myocardial
perfusion reserve (MPR). An earlier PET study showed
no correlation between Doppler ultrasound flow mea-
surement in the forearm and dipyridamole-induced
myocardial hyperemia,2 whereas another study compar-
ing acetylcholine-induced myocardial hyperemia to
brachial artery dilation did find some weak correlation.4
A possible limitation of these previous studies is the dif-
ferences in technique between the myocardial and the
peripheral measurements. The microvascular component
of myocardial and peripheral perfusion may however
differ also. To evaluate this possible limitation we stud-
ied the peripheral and myocardial perfusion in rest
[13N]ammonia PET and during adenosine stress
[13N]ammonia PET and calculated the MPR and
peripheral perfusion reserve (PPR) in patients with doc-
umented coronary artery disease (CAD), microcar-
diovascular disease (cardiac syndrome X, SX), idiopathic
dilating cardiomyopathy (DCM), and normal controls
(NC). By including three separate clinical entities we
intended also to compare the differences between ath-
erosclerotic macro- and microvascular disease (CAD) and
microvascular disease without documented macrovascu-
lar disease as found in cardiac syndrome X and idiopathic
DCM and ascertain whether peripheral perfusion
responses were more strongly linked to any of the
underlying pathologies. Perfusion reserve is an important
parameter for prognosis in patients with cardiovascular
disease5 and will be used in this study.
The aim of this study is to evaluate the correlation
between the myocardial and the peripheral perfusion
reserve when tested during the same PET perfusion session.
METHODS
Study Population
The study population comprised 58 subjects retrospec-
tively, submitted for cardiac [13N]ammonia PET analysis in
our centre between 1995 and 2003, whose scans allowed for
calculation of perfusion in an appropriate area of the proximal
upper limb. These patients were divided into four groups: (I)
15 patients (9 male, 6 female) with documented CAD, defined
as wall irregularities on coronary angiogram; (II) 14 patients (4
males, 10 females) with SX, defined as typical chest pain,
positive exercise ECG-changes and a normal coronary angio-
gram; (III) 16 patients (12 males, 4 females) with idiopathic
DCM without prior evidence of CAD or myocardial infarction;
and (IV) 13 healthy control subjects (2 males, 11 females)
without cardiac or pulmonary disease.
Patients’ current medication was continued, except for
dipyridamole and diuretics due to interaction with adenosine
and to prevent urinary urge during acquisition, respectively.
Characteristics of each group are shown in Table 1.
Acquisition Protocol
PET scans were performed on an ECAT EXACT HR ?
PET camera (Siemens Medical Systems, Knoxville, TN, USA).
Positioning of the subjects was done with the aid of a rectilinear
scan. Photon attenuation was measured using an external ring
source filled with 68Ge/68Ga and data were automatically cor-
rected for accidental coincidence and dead time. Patients were
continuously monitored with 12-lead electrocardiography and
blood pressure was obtained every 10 minutes. During adeno-
sine-induced stress, blood pressure was measured every minute.
Myocardial perfusion was measured using [13N]ammonia as a
perfusion tracer and adenosine as the pharmacological stress
agent. After injection of 400 MBq of [13N]ammonia a dynamic
rest imaging was performed for 15 minutes. Adenosine stress
imaging was performed identically after 140 lg/kg/min of
adenosine infusion 3 minutes prior to and 3 minutes following
the injection of 400 MBq of [13N]ammonia.
Measurement of Myocardial Perfusion
The quantification of myocardial perfusion has been
described previously.6 In summary, [13N]ammonia was
injected intravenously over 30 seconds while acquisition of a
dynamic sequence of images to obtain time-activity curves
from the blood pool and from the myocardial tissue was star-
ted. 17 regions of interest (ROIs) were placed within the left
ventricular myocardium in the three territories of the major
coronary arteries. These ROIs were subsequently copied to the
dynamic image sequence. In this way, myocardial tissue time-
activity curves for [13N]ammonia were obtained. The arterial
input function was obtained from a small ROI in the left
ventricular blood pool. Reproducibility has been assessed
previously.7 Myocardial perfusion was calculated by fitting the
corrected tissue and blood pool time-activity curves to a val-
idated 2-tissue-compartment model for [13N]ammonia using
the Hutchins model.8
Measurement of Peripheral Perfusion
For each study transmission images were used to draw six
ROIs around the upper limb (opposite to the injected arm) in
six consecutive slices, excluding the areas of highest density
correlating with the location of bone. These ROIs were then
copied to the dynamic sequences to obtain time-activity curves
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for [13N]ammonia in the peripheral vascular bed. This is
illustrated in Figure 1. A small ROI in the left ventricular
blood pool was used for the arterial input function. Peripheral
perfusion was calculated by fitting the tissue and blood pool
time-activity curves to the aforementioned 2-tissue-compart-
ment model for [13N]ammonia. Since the myocardial
perfusion and peripheral perfusion were calculated in the same
studies, all circumstances (blood pressure, heart rate) were
equal for both measurements.
Perfusion Reserve Calculation
Myocardial and peripheral perfusion flow reserves were
calculated by dividing the perfusion results of the adenosine
[13N]ammonia stress study by the results of the [13N]ammo-
nia rest study.
Statistical Analysis
The mentioned values are the mean values ± SD. standard
error of estimates (SEE) was added in graphs. A paired t test or
the nonparametric Wilcoxon signed rank test was used to
compare individual values. Correlations were sought by stan-
dard linear regression. A P value \.05 was considered
significant.
RESULTS
Hemodynamics
The hemodynamic values are listed in Table 2 for
the four patient groups. During adenosine infusion, there
were no statistically significant changes in blood pres-
sure in any of the groups. The heart rate and accordingly
the rate-pressure product increased in all groups, though
the increase was not statistically significant in the
SX-group. The highest increase was noted in the DCM-
group, showing a mean rise in heart rate of 50%, as
opposed to the other groups which all showed less than
25% increase in heart rate.
Table 1. Patients’ characteristics
CAD SX DCM Control
N 15 14 16 13
Mean age (range) 64 (50–81) 55 (34–76) 78 (45–91) 58 (48–73)
Use of b-blocker (%) 100 21 75 54
Use of ACE-inhibitor (%) 67 36 81 8
Use of vasodilator (%) 13 57 50 38
Use of statin (%) 53 43 0 15
Use of diuretics (%) 27 14 56 14
Known with diabetes (%) 0 7 6 8
CAD, Coronary artery disease; SX, syndrome X, DCM, dilating cardiomyopathy
Figure 1. Measurement of peripheral perfusion. Regions of interest (ROI) are drawn on the
transmission dataset in the upper limb, excluding the area of the humerus. These ROI are copied to
the perfusion dataset (large arrows) and the measured time/activity curve is fitted to the
compartment model for [13N] ammonia. In the opposite arm the influx of activity from the infusion
site is just visible (small arrow).
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Myocardial Perfusion (Reserve)
The mean resting flow in the myocardium in mL/
min/100 g per group was: CAD 60.3 ± 16.2; SX 83.4 ±
24.6; DCM 50.4 ± 9.8; and NC 70.3 ± 15.8. During
adenosine infusion, the measurements were: CAD
112.8 ± 26.4; SX 115.8 ± 40.6; DCM 80.1 ± 36.9; and
NC 184.7 ± 47.6. All these changes were highly sig-
nificant (CAD: P = .007, SX: P = .002, DCM: P =
.005, NC: P = .005). The resulting calculated MPR per
group was: CAD 1.99 ± 0.47; SX 1.39 ± 0.31; DCM
1.72 ± 0.69; NC 2.91 ± 0.78. The changes in myocar-
dial perfusion between rest and pharmacological stress
are shown in Figure 2.
Peripheral Perfusion (Reserve)
The mean resting flow in the peripheral vasculature
in mL/min/100 g per group was: CAD 3.0 ± 1.5; SX
6.5 ± 3.4; DCM 1.6 ± 0.8; and NC 3.9 ± 1.5. During
adenosine infusion, the measurements were: CAD
3.1 ± 2.1; SX 8.8 ± 6.5; DCM 2.2 ± 1.0; and NC
5.3 ± 3.4. None of these changes were significant, nor
were the differences between the groups. The resulting
calculated PPR per group was: CAD 1.30 ± 0.79; SX
1.36 ± 0.71; DCM 1.60 ± 1.22; NC 1.27 ± 0.63. No
correlation was found with the rate-pressure product.
The changes in peripheral perfusion between rest and
pharmacological stress are shown in Figure 3.
Comparison Between the Different Groups
Myocardial blood flow during adenosine infusion
was significantly higher in normal controls compared to
all other groups (P \ .001 vs all groups), as was the
MPR (P B .001 vs all groups).
Myocardial blood flow was significantly higher in
SX compared to DCM (P = .03) and in CAD compared
to DCM (P = .02). The difference between CAD and
SX was not significant.
The MPR was significantly higher in CAD com-
pared to SX (P = .001) whereas all other groups
comparisons showed no significant differences.
Peripheral blood flow during adenosine infusion
was significantly higher when comparing NC to DCM
(P = .015), SX to CAD (P = .014), and SX to DCM
(P = .005), other comparisons showed no significant
differences.
There were no significant differences in PPR
between any of the groups.
Correlation Between Myocardial and
Peripheral Blood Flow During Adenosine
Infusion
No significant correlations were found between the
two circulatory beds during adenosine infusion for the
group as a whole (r = 0.13, SEE = 54.32, P = .36) or
any of the subgroups (CAD: r = 0.03, SEE = 1.46;
SX: r = 0.16, SEE = 43.57; DCM: r = -0.35, SEE =
37.15; NC: r = -0.31, SEE = 49.57).
Correlation Between MPR and PPR
The correlations between the myocardial perfusion
reserve and the peripheral perfusion reserve in the
separate groups are shown in Figure 4. No correla-
tions were found in the whole group (r = -0.07,
SEE = 0.70, P = .47), or for any of the four separate
groups (values provided in Figure 4). Figure 5 shows
the Bland-Altman plot for the comparison in the
whole group.
Table 2. Hemodynamic values
CAD SX DCM Control
Heart rate at rest per minute 64 ± 10 82 ± 17 76 ± 9 65 ± 7
Heart rate at stress per minute 72 ± 11* 85 ± 23 114 ± 10* 81 ± 14*
Systolic blood pressure at rest (mmHg) 131 ± 16 159 ± 3 102 ± 5 132 ± 9
Systolic blood pressure at stress (mmHg) 136 ± 15 144 ± 8 95 ± 6 132 ± 13
Diastolic blood pressure at rest (mmHg) 75 ± 11 89 ± 9 57 ± 6 78 ± 7
Diastolic blood pressure at stress (mmHg) 79 ± 8 85 ± 8 66 ± 7 76 ± 7
Rate-pressure product at rest 8340 11939 7752 8526
Rate-pressure product at stress 9757* 12166 10830* 10704*
CAD, Coronary artery disease; SX, syndrome X, DCM, dilating cardiomyopathy
All values mean ± SD
* Statistically significant increase compared to rest (P\0.05)
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DISCUSSION
In our study, we evaluated the effects of vasodila-
tor-stress between the two vascular beds in various
underlying cardiovascular pathologies.
Our data showed that during the same dose of i.v.
adenosine infusion the response in perfusion in the heart
and the musculature of the upper limb is not related.
Although we noted a minor increase in blood flow in the
upper limb, this response was not statistically significant
and showed no differences between normal controls and
the three patient groups.
There has been an interest in the past in the corre-
lation between abnormalities in the coronary and the
peripheral vasculature. Endothelial dysfunction has been
linked to atherosclerotic risk factors, paving the way for
ultrasound-based assessment of endothelial dysfunction.
It has been shown that endothelial dysfunction in the
brachial artery has a predictive value for coronary artery
disease.1
The resting myocardial perfusion values and the
hemodynamic response to adenosine infusion in our
patient groups were comparable to other findings,9-11
even though changes in the SX-group were not statisti-
cally significant. The myocardial blood flow response to
vasodilator-stress in our four patient groups was also
comparable to other studies.3,5,12,13 As expected, coro-
nary perfusion increased more than 2-fold in normal
controls, whereas in the three patient groups with vas-
cular disease these diseases blocked an adequate
increase in blood flow. In the group with CAD, inade-
quate blood flow response was more localized due to the
relatively focal lesion of the vasculopathy when
Figure 2. Myocardial perfusion at rest vs during adenosine stress. CAD, Coronary artery disease;
NC, normal controls; SX, syndrome X; DCM, dilating cardiomyopathy; MBF, myocardial blood
flow.
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compared to the SX and DCM groups. As the blood flow
response is normal in non-atherosclerotic vessels in
patients with CAD, in contrast to generally diseased
myocardium in SX and DCM, the global MPR in CAD
will be less affected. The relatively low MPR found in
the SX group is at least partially based on a higher blood
flow in rest, presumably due to the inherently higher
metabolic rate in these patients. A higher resting flow
further decreases the ratio between rest and stress flow
measurements, explaining why the MPR in this group
was lower than in any of the other groups even though
the blood flow during adenosine infusion was compa-
rable to that of the CAD group.
The resting blood flow in the peripheral circulation,
in our case mostly in the biceps and triceps muscles, was
also comparable to findings in different peripheral
muscles in other studies.14,15
A major difference between our study and previous
described literature about the relation between myocar-
dial and peripheral blood flow is the used method of a
single session adenosine infusion. Most other studies
used ischemia-driven blood flow increase in the upper
limb after a period of occlusion, usually by means of an
inflatable cuff, coupled with hand exercises.
Though the vasodilative effects of adenosine have
been reported over 8 decades ago,16 the precise mecha-
nism through which it induces vasodilation is still not
completely understood. Biaggioni wrote a commentary17
where he listed a number of mechanisms that may play a
role in the vasodilative effects of adenosine, pointing out
that the findings of various studies on the subject are
contradictory. In an overview article on the role of PET in
the understanding of coronary physiology, Schindler
et al18 describe the mechanism of dipyridamole and
adenosine as being a mixture of predominantly endothe-
lium-independent flow responses, with shear sensitive
endothelial components adding to these responses.
Adenosine-induced hyperemia is therefore partially
endothelium-independent and partially endothelium-
dependent.
It is therefore possible that the responses elicited with
intravenous adenosine differ significantly from other
Figure 3. Peripheral perfusion at rest vs during adenosine stress. CAD, Coronary artery disease;
NC, normal controls; SX, syndrome X; DCM, dilating cardiomyopathy; PBF, peripheral blood flow.
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vasodilative stimuli such as hypoxia (mostly myogenic
with supposed added effects from prostaglandins and
adenosine), acetylcholine (fully endothelium dependent),
or papaverine (smooth muscle relaxation) due to the dif-
ferent pathways that govern each of these responses, and
that these responses in turn differ between the coronary
and the systemic circulation. Anderson et al4 did find some
weak correlation between myocardial vessel response to
acetylcholine and flow-mediated brachial artery diameter
measurements, though with significant scatter in their
findings. In this study, sublingual nitroglycerin, a non-
endothelium dependent vasodilator, did not show the
same effect as reactive hyperemia, showing the variability
in response to differing vasodilators.
Even dipyridamol elicits a different response to
purely intravenous adenosine as it increases not only the
intravenous but also the interstitial levels of adenosine.
This affects the peripheral vasculature in a different way
than purely intravenous administration of adenosine
does, as adenosine concentrations are raised concomi-
tantly on both sides of the vascular wall.
In conscious subjects, systemic infusion of adeno-
sine has been shown to stimulate sympathetic tone, most
probably due to stimulation of arterial chemoreceptors.19
Whether this affects flow in myocardial and peripheral
vascular beds differently is not known.
Our data do suggest a possible explanation for the
differences between the two perfusion reserves, in that
Figure 4. Correlations between MPR and PPR. CAD, Coronary artery disease; NC, normal
controls; SX, syndrome X; DCM, dilating cardiomyopathy; PPR, peripheral perfusion reserve;
MPR, myocardial perfusion reserve.
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resting flow in the myocardial vasculature is about 20
times higher than in the periphery. As the total delivered
dose of adenosine is flow-dependent, the dose delivered
to the myocardial vessels will also be about 20 times
higher than peripherally. This may account for the
minimal effect of adenosine on the peripheral blood flow
in all four patient groups, as a threshold dose may not be
reached in the periphery due to the significantly lower
flow in the resting phase.
Few data exist on peripheral blood flow during
intravenous adenosine stress only, especially as measured
with PET. Heinonen et al14 in their study using [15O]-H2O
as the PET perfusion tracer, reported an increase in
peripheral muscle perfusion during adenosine infusion
comparable to exercise that was absent in our study pop-
ulation. However, in their study adenosine was infused
directly into the femoral artery which differs from our
intravenous infusion. They also reported a decline in
blood flow in the opposite limb during adenosine infusion,
indicating that the hyperemic response to adenosine was
localized rather than widespread throughout the body
after passing into the systemic circulation.
Pedrinelli et al20 found that in patients with sys-
temic hypertension the peripheral vascular reserve was
lower than the myocardial reserve without correlation
between the two values. This patient group is an inter-
esting comparison with the patient groups with different
included pathologies in our study. Again due to the
retrospective nature of our study, we could not specify
such a subgroup of patients with hypertension for
inclusion. It is difficult to hypothesize about any relation
between our current findings and those of Pedrinelli
et al, because peripheral vasodilation was based on
postischemic hyperemia as opposed to adenosine
infusion.
CONCLUSION
In this study, we confirmed that perfusion reserves
of the myocardial and the peripheral microvasculature
during the same PET session were different, indicating
different levels of response for the two vascular beds
during the same intravenous adenosine infusion session.
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